Olanzapine: preclinical pharmacology and recent findings
Moore, N.
Nihon Shinkei Seishin Yakurigaku Zasshi 18(3): 91-95
1998
ISSN/ISBN: 1340-2544 PMID: 9800200 Document Number: 487159
Document emailed within 1 workday
Related Documents
Jann, M.W. 1998: Preclinical pharmacology of metrifonate PharmacoTherapy 18(2 Part 2): 55-67; Discussion: 79-82Cohen, M.L.; Fuller, R.W.; Kurz, K.D.; Parli, C.J.; Mason, N.R.; Meyers, D.B.; Smallwood, J.K.; Toomey, R.E. 1988: Preclinical pharmacology of a new serotonergic receptor antagonist, LY281067 Journal of Pharmacology and Experimental Therapeutics 244(1): 106-112
Richelson, E. 1996: Preclinical pharmacology of neuroleptics: focus on new generation compounds Journal of Clinical Psychiatry 57(Suppl): 4-11
Newman, R.A.; Fuentes, A.; Covey, J.M.; Benvenuto, J.A. 1994: Preclinical pharmacology of the natural marine product dolastatin 10 (NSC 376128) Drug Metabolism and Disposition: the Biological Fate of Chemicals 22(3): 428-432
Walton, M.I.; Gibson, W.; Aherne, G.W.; Lawrence, N.; Stephens, T.C.; Smith, M.N.; Jackman, A.L. 1996: Preclinical pharmacology of CB30900, a novel dipeptide inhibitor of thymidylate synthase, in mice Journal of Pharmacology and Experimental Therapeutics 277(2): 909-916
Kaiser, B.; Kirchmaier, C.M.; Breddin, H.K.; Fu, K.; Fareed, J. 1999: Preclinical biochemistry and pharmacology of low molecular weight heparins in vivo--studies of venous and arterial thrombosis Seminars in Thrombosis and Hemostasis 25(Suppl 3): 35-42
Haslemo, T.; Refsum, H.; Molden, E. 2011: The effect of ethinylestradiol-containing contraceptives on the serum concentration of olanzapine and N-desmethyl olanzapine British Journal of Clinical Pharmacology 71(4): 611-615
Gallouedec, C.; Bouvier, M.; Castelain, G.; Grand, G.; Brocard, H. 1972: Preclinical cytological findings in the diagnosis of airways cancers Revue de Tuberculose et de Pneumologie 36(1): 5-18
Kábrt, J. 1995: New findings in diet therapy and nutritional pharmacology Vnitrni Lekarstvi 41(5): 348-351
Duchêne-Marullaz, P. 1977: Pharmacology, clinical pharmacology and therapeutic effects of Royat's thermal gas Semaine des Hopitaux. Therapeutique 53(7-8): 361-362
Vyas, B. 2001: European Association of Clinical Pharmacology and Therapeutics--Fifth Congress. Clinical pharmacology: from molecule to society--bridging the gap via Man IDrugs: the investigational drugs journal 4(10): 1133-1137
Poulsen, H.Enghusen.; Schmitz, O.E.; Brøsen, K. 2002: Clinical pharmacology 2001--important events. The Danish Society of Clinical Pharmacology Ugeskrift for laeger 164(12): 1652
Sofia-Gabrion, C.Klaus.; Ali Yahia, Y.; Holzer, L. 2007: Olanzapine and blepharoclonus Journal of Clinical Psychiatry 68(9): 1443-1444
Nagy, A.; Tényi, T.; Lénárd, K.; Herold, R.; Wilhelm, F.; Trixler, M. 2001: Olanzapine and pregnancy Orvosi Hetilap 142(3): 137-138
Lee, D.W.; Fowler, R.B. 2003: Olanzapine/risperidone and diabetes risk Journal of Clinical Psychiatry 64(7): 847-8; Author Reply 848
Vieta, E. 2003: Divalproex versus olanzapine in mania Journal of Clinical Psychiatry 64(10): 1266; Author Reply 1266-7
2003: Olanzapine and mirtazapine for multiple palliation Journal of Supportive Oncology 1(1): 64
Chong, S.A.; Remington, G. 1999: Plasma olanzapine and clinical response Journal of Clinical Psychopharmacology 19(2): 192-194
Belli, H.; Sertbas, Y.; Bayik, Y. 2005: Olanzapine-induced diabetes due to pancreatitis Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 24(6): 273
Anand, H.S. 1999: Olanzapine in an intensive care unit Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 44(4): 397